Results 131 to 140 of about 1,637,196 (313)

Some curiosites about the Engel method to estimate equivalence scales [PDF]

open access: yes
This paper lends legitimacy to the food share as an indicator of welfare by demonstrating the conditions necessary in empirical work for the Engel method of estimating equivalence scales to provide an exact measure of welfare.
Federico Perali
core  

Scales Fine Arts Center Theatre (Wake Forest University)

open access: yes, 1970
Scales Fine Arts Center theatre, view from stage of seats and ...
McNabb Studio
core   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Interview with John B. Scales

open access: yes, 2004
John B. Scales continues in this second part of his interview to describe the supposed first live prisoner of war exchange between the Americans and Germany. He explains that he was the unofficial photographer for his unit and shows some photographs from
Scales, John B.
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Dedication of Scales Fine Arts Center, Wake Forest University, 1973

open access: yes, 1973
Wake Forest University President James Ralph Scales in academic regalia, with unidentified woman, beside cornerstone of Scales Fine Arts Center.on back of photo penciled date 10/20 ...
Ray, Bill III
core  

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

open access: yesMolecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy   +10 more
wiley   +1 more source

Intervals of Existence of Dynamic Equations on Particular Time Scales

open access: yes, 2012
Color poster with text, graphs, and diagrams.This study analyzed dynamic equations on time scales and the intervals of existence of solutions on a special class of time scales consisting of a finite number of intervals.University of Wisconsin--Eau Claire
Paquin, Robert J.
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy